Connecting existing downstream steps delivers the value of continuous bioprocessing, says executive Jon Coffman at BioProcess ...

The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...

Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...

Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...

Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its ...

Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...

From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...

Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...

Learn strategies for controlling trace metals, polysorbate degradation, and other key formulation risks that can compromise ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large molecule formats.

HPLC continues to meet such demands through advances in column chemistry, instrument performance, and software, allowing laboratories to characterize increasingly complex molecules with greater ...

Helping Downstream Processing To Follow Upstream Innovation. Complex biomolecules place unprecedented demands on conventional purification platforms. Alth ...